Catherine A. Cargo

St James's University Hospital
Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis.

Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis.

Journal: Blood neoplasia

Published: April 22, 2026

Deep phenotyping ILCs and T cells: A comparative analysis protocol for conventional and spectral flow cytometry.

Deep phenotyping ILCs and T cells: A comparative analysis protocol for conventional and spectral flow cytometry.

Journal: STAR protocols

Published: March 02, 2026

The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

Journal: EJHaem

Published: January 29, 2026

Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research Network.

Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research Network.

Journal: International journal of cancer

Published: November 05, 2025

Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Journal: British journal of haematology

Published: September 03, 2025

Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study.

Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study.

Journal: Haematologica

Published: August 24, 2025

COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research Network.

COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research Network.

Journal: British journal of haematology

Published: July 17, 2025

Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.

Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.

Journal: British journal of haematology

Published: February 19, 2025

Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time.

Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time.

Journal: The Lancet. Haematology

Published: December 16, 2024

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 13, 2024

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 13, 2024

Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.

Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.

Journal: The Lancet. Rheumatology

Published: December 05, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026